Quarterly EPS earnings growth: Bio-Rad Corp (BIO)

Bio-Rad Laboratories Inc - graphic logo of issuer BIO

Bio-Rad Laboratories (BIO) is betting on internal efficiency, limiting mergers to targeted acquisitions of tests. Growth is based on the implementation of ddPCR systems and rising expenditures by biotech startups. Comparing the quarterly EPS trajectory on GURU.Markets, we see that 235.00 reflects the latest value of the metric. Business stability is ensured by installed instruments, which generate constant demand for proprietary consumables amidst fierce technological competition.

Bio-Rad (BIO) - Year-over-year net earnings per share change for the last twelve months from 07/04/2022 to 11/11/2026

Metric breakdowns and analytics for Bio-Rad Corp (BIO)

- market value and analyst target forecast:
Price Chart Bio-Rad|BIO - Analyst Median Target
- company stock exchange capitalization indicators:
Market Capitalization Bio-Rad Corp|BIO - Total Company Value
- balance sheet net asset value indicators:
Book Value per Share Bio-Rad|BIO - Book Valuation of Business|Market Value to Book Value Ratio bio-rad.com|BIO - Company Assets
- debt burden and liquidity indicators:
Total Debt to Equity Ratio Bio-Rad Laboratories|BIO - Long-Term Indebtedness to Equity|Short-Term Debt to Equity Bio-Rad Laboratories|BIO - Aggregate Debt Obligations|Debts to Book Capitalization Bio-Rad Corp|BIO - Company Long-Term Debts|Company Short-Term Debts Bio-Rad|Quick Liquidity Indicator bio-rad.com
- earnings and valuation multiples indicators:
BIO - Final Profit|Expected Profit Bio-Rad Laboratories|BIO - Price to Earnings Ratio|Forward P/E Multiple Bio-Rad Laboratories Inc|BIO - PEG Multiple|EV/EBITDA Multiple Bio-Rad Corp|BIO - Profit before payment of interest, taxes and amortization|Earnings per share for the last twelve months Bio-Rad|BIO - Net earnings per one share for the last twelve months|Year-over-year earnings per share growth for the last twelve months bio-rad.com|BIO - Earnings per share increase in current year|Earnings growth forecast for next year Bio-Rad Laboratories
Summary company analytics:Bio-Rad - BIO
Finished products of Bio-Rad Laboratories

This indicator measures the dynamics of earnings per share, identifying the business's ability to scale profitability faster than operating expenses. Investors utilize this metric to assess margin resilience against inflationary pressure. By analyzing the quarterly EPS growth rate, one can determine the actual efficiency of capital management. For Bio-Rad Laboratories (BIO), this is confirmed by stable capacity utilization. The absence of equipment depreciation and the precise configuration of production facilities ensure the predictability of financial results.

Competitor analysis

Agilent (A) - Year-over-year earnings per share growth for the last twelve months|DGX - Year-over-year net earnings per share change for the last twelve months|ILMN (Illumina Corp) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last twelve months EXAS|Quarterly EPS earnings growth RVTY|Year-over-year net earnings per share change for the last twelve months anbio.com|Year-over-year earnings per share growth for the last twelve months Sotera Health SHC|Quidel Corporation (QDEL) - Earnings per share growth in annualized terms for the last twelve months|OPK: Year-over-year net earnings per share growth for the last 12 months|Net earnings per share growth for the trailing year CareDx, Inc (CDNA)|Maravai LifeSciences (MRVI) - Year-over-year earnings per share growth for the last twelve months|fulgentgenetics.com - Year-over-year earnings per one share growth for the last 12 months|LAB (Standard BioTools) - Quarterly EPS earnings growth|Quarterly EPS earnings growth Cytek Biosciences Inc|Quarterly EPS earnings growth OSUR|exagen.com - Year-over-year earnings per share growth for the last 12 months|MDxHealth SA - Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per one share growth for the last 12 months LUCD|PRE - Year-over-year earnings per share growth for the last twelve months|IMDX: Year-over-year earnings per share growth for the last twelve months|TRIB: Quarterly EPS earnings growth|ProPhase Labs Corp (PRPH) - Quarterly EPS earnings growth|AIMD (Ainos, Inc.) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last twelve months CODX|Year-over-year earnings per share growth for the last twelve months HeartSciences (HSCS)|BMRA - Earnings per share growth in annualized terms for the last twelve months|Year-over-year earnings per share growth for the last twelve months Cardio Diagnostics Holdings CDIO|Year-over-year earnings per one share growth for the last 12 months ONCO|Virax Biolabs Group - Quarterly EPS earnings growth|BJDX - Quarterly EPS earnings growth|AWH (Aspira Women's Health Inc.) - Year-over-year net earnings per share growth for the last 12 months|AXDX: Year-over-year earnings per share growth rate for the last twelve months|Year-over-year earnings per share growth for the last twelve months CENTOGENE|Earnings per share growth in annualized terms for the last twelve months Enzo ENZ|Year-over-year earnings per share growth for the last twelve months Fresh2 Group Limited (FRES)|GENE (gtglabs.com) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth ME (23andMe)|Year-over-year net earnings per share change for the last twelve months Psychemedics Corp. (PMD)